Originally published by our sister publication, Pharmacy Practice News
With the approval of tapinarof (Vtama, Dermavant) cream, the FDA allowed the marketing of the first steroid-free topical medication for the treatment of adults with plaque psoriasis.
The FDA approval of tapinarof cream, an aryl hydrocarbon receptor agonist, is based on results from the pivotal phase 3 PSOARING studies (PSOARING 1, ClinicalTrials.gov Identifier:NCT03956355; PSOARING 2, ClinicalTrials.gov Identifier: